Yiheng Capital Management, L.P. Iveric Bio, Inc. Transaction History

Yiheng Capital Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$18.67 - $24.56 $27.4 Million - $36.1 Million	-1,469,757 Reduced 40.68%	2,143,497 $52.2 Million
Q3 2022 Nov 14, 2022	SELL	$9.4 - $18.59 $13.6 Million - $26.9 Million	-1,445,331 Reduced 28.57%	3,613,254 $64.8 Million
Q3 2021 Nov 15, 2021	BUY	$7.07 - $17.5 $21,917 - $54,250	3,100 Added 0.06%	5,058,585 $82.2 Million
Q2 2021 Aug 16, 2021	BUY	$5.69 - $7.17 $12.9 Million - $16.3 Million	2,271,402 Added 81.59%	5,055,485 $31.9 Million
Q1 2021 May 17, 2021	BUY	$5.08 - $6.89 $13.3 Million - $18.1 Million	2,626,407 Added 1665.7%	2,784,083 $17.2 Million
Q4 2020 Feb 16, 2021	BUY	$5.65 - $7.66 $890,869 - $1.21 Million	157,676 New	157,676 $1.09 Million

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Yiheng Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Yiheng Capital Management, L.P. with notifications on news.